NEW KOREA INDUSTRIAL CO., LTD.

Based in South Korea, NEW KOREA INDUSTRIAL CO. , LTD. specializes in the development and production of nuclear medicine products and medical devices, serving healthcare professionals and institutions with advanced diagnostic and therapeutic solutions. Founded in 1967, NEW KOREA INDUSTRIAL CO.

, LTD. is headquartered in Seoul, South Korea. The company focuses on the nuclear medicine sector and medical device manufacturing. Young-deok Kim serves as the CEO, actively leading the company's strategic initiatives and operations.

NEW KOREA INDUSTRIAL CO. , LTD. specializes in the development and production of nuclear medicine products and medical devices. Their core offerings include radiopharmaceuticals, in vitro diagnostic medical devices, research reagents, medical equipment accessories, and isotopic therapies.

These products facilitate accurate diagnosis and effective treatment in various medical fields, particularly in oncology and cardiology. The company serves a diverse client base that includes hospitals, clinics, and research institutions primarily across South Korea, with potential markets extending to other regions in Asia. The revenue model of NEW KOREA INDUSTRIAL CO. , LTD.

is structured around B2B transactions, primarily involving partnerships with healthcare facilities and institutions that utilize their medical products. The company engages in direct sales agreements with hospitals and clinics, providing access to essential medical devices and radiopharmaceuticals. Pricing plans for products depend on the volume of purchase and the nature of the agreements established with clients, which may involve standard contracts for recurring supplies. Flagship offerings such as radiopharmaceuticals and diagnostic devices play a significant role in revenue generation.